DOP2014000254A - Metodo para la preparacion de compuestos de triazol - Google Patents

Metodo para la preparacion de compuestos de triazol

Info

Publication number
DOP2014000254A
DOP2014000254A DO2014000254A DO2014000254A DOP2014000254A DO P2014000254 A DOP2014000254 A DO P2014000254A DO 2014000254 A DO2014000254 A DO 2014000254A DO 2014000254 A DO2014000254 A DO 2014000254A DO P2014000254 A DOP2014000254 A DO P2014000254A
Authority
DO
Dominican Republic
Prior art keywords
triazol
preparation
morpholin
pyrazol
pyrimidin
Prior art date
Application number
DO2014000254A
Other languages
English (en)
Spanish (es)
Inventor
Hans Christian Militzer
Johannes Eggert
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48325714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2014000254(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of DOP2014000254A publication Critical patent/DOP2014000254A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DO2014000254A 2012-05-08 2014-11-07 Metodo para la preparacion de compuestos de triazol DOP2014000254A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12167152 2012-05-08

Publications (1)

Publication Number Publication Date
DOP2014000254A true DOP2014000254A (es) 2016-01-31

Family

ID=48325714

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2014000254A DOP2014000254A (es) 2012-05-08 2014-11-07 Metodo para la preparacion de compuestos de triazol

Country Status (36)

Country Link
US (1) US10301289B2 (xx)
EP (1) EP2847183B1 (xx)
JP (1) JP6149104B2 (xx)
KR (1) KR102086389B1 (xx)
CN (1) CN104411704B (xx)
AP (1) AP2014008089A0 (xx)
AU (1) AU2013258107B2 (xx)
BR (1) BR112014027564B1 (xx)
CA (1) CA2872726C (xx)
CL (2) CL2014003003A1 (xx)
CO (1) CO7121324A2 (xx)
CR (1) CR20140514A (xx)
CU (1) CU20140128A7 (xx)
DK (1) DK2847183T3 (xx)
DO (1) DOP2014000254A (xx)
EA (1) EA027804B1 (xx)
ES (1) ES2641205T3 (xx)
HK (1) HK1208027A1 (xx)
HR (1) HRP20171321T1 (xx)
HU (1) HUE034430T2 (xx)
IL (1) IL235441A (xx)
LT (1) LT2847183T (xx)
MX (1) MX350519B (xx)
MY (1) MY184577A (xx)
NZ (1) NZ701661A (xx)
PE (1) PE20142453A1 (xx)
PH (1) PH12014502482A1 (xx)
PL (1) PL2847183T3 (xx)
PT (1) PT2847183T (xx)
RS (1) RS56255B1 (xx)
SG (2) SG11201407043PA (xx)
SI (1) SI2847183T1 (xx)
TN (1) TN2014000469A1 (xx)
UA (1) UA116349C2 (xx)
WO (1) WO2013167552A1 (xx)
ZA (1) ZA201408571B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6921863B2 (ja) * 2016-05-03 2021-08-18 バイエル ファーマ アクチエンゲゼルシャフト ５−ヒドロキシアルキル置換１−フェニル−１，２，４−トリアゾール誘導体を生産する方法
CN108084099B (zh) * 2017-12-20 2019-01-29 天驰药业有限公司 一种1,2,3-三氮唑化合物的合成方法
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents
EP3888684A1 (en) 2020-03-31 2021-10-06 Bayer Animal Health GmbH Composition having improved voluntary acceptance
CN114264752B (zh) * 2021-12-29 2023-08-15 北京金城泰尔制药有限公司 溴乙酸甲酯的检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135184A (da) 1983-03-03 1984-10-10 Riker Laboratories Inc Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
US4752910A (en) 1984-10-30 1988-06-21 Prime Computer, Inc. Method and apparatus for continuous after-imaging
UY27813A1 (es) * 2002-05-31 2003-12-31 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
TWI335913B (en) 2002-11-15 2011-01-11 Vertex Pharma Diaminotriazoles useful as inhibitors of protein kinases
CN1871208A (zh) * 2003-10-30 2006-11-29 默克公司 作为大麻素受体调节剂的芳烷基胺
US7745630B2 (en) 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
DE102008020113A1 (de) * 2008-04-23 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Substituierte Dihydropyrazolone und ihre Verwendung
JP2008539220A (ja) 2005-04-26 2008-11-13 ファイザー・リミテッド バソプレシンアンタゴニストとしてのトリアゾール誘導体
EP1885713A1 (en) 2005-05-18 2008-02-13 Pfizer Limited 1, 2, 4 -triazole derivatives as vasopressin antagonists
DE102006050516A1 (de) * 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dihydropyrazolone und ihre Verwendung
DE102010041236A1 (de) * 2010-09-23 2012-03-29 Osram Ag Optoelektronisches Halbleiterbauelement
DE102010044131A1 (de) * 2010-11-18 2012-05-24 Bayer Schering Pharma Aktiengesellschaft Substituiertes Natrium-1H-pyrazol-5-olat

Also Published As

Publication number Publication date
CL2014003003A1 (es) 2015-02-13
AP2014008089A0 (en) 2014-11-30
EP2847183A1 (de) 2015-03-18
NZ701661A (en) 2016-08-26
EA027804B1 (ru) 2017-09-29
HRP20171321T1 (hr) 2017-10-20
SG11201407043PA (en) 2014-12-30
HUE034430T2 (en) 2018-02-28
LT2847183T (lt) 2017-09-25
JP2015516403A (ja) 2015-06-11
CN104411704B (zh) 2017-12-22
BR112014027564B1 (pt) 2022-05-03
CU20140128A7 (es) 2015-03-30
WO2013167552A1 (de) 2013-11-14
ZA201408571B (en) 2016-03-30
PT2847183T (pt) 2017-10-02
SG10201609319YA (en) 2016-12-29
EP2847183B1 (de) 2017-06-21
US10301289B2 (en) 2019-05-28
UA116349C2 (uk) 2018-03-12
PE20142453A1 (es) 2015-01-17
SI2847183T1 (sl) 2017-10-30
BR112014027564A2 (xx) 2017-08-22
CR20140514A (es) 2014-12-02
ES2641205T3 (es) 2017-11-08
CA2872726C (en) 2020-07-07
KR102086389B1 (ko) 2020-03-09
TN2014000469A1 (en) 2016-03-30
EA201492032A1 (ru) 2015-04-30
MY184577A (en) 2021-04-06
IL235441A (en) 2017-09-28
PH12014502482A1 (en) 2015-01-12
CA2872726A1 (en) 2013-11-14
KR20150018534A (ko) 2015-02-23
CN104411704A (zh) 2015-03-11
CO7121324A2 (es) 2014-11-20
AU2013258107A1 (en) 2014-11-27
MX350519B (es) 2017-09-08
US20150087827A1 (en) 2015-03-26
DK2847183T3 (en) 2017-10-02
MX2014013448A (es) 2014-12-08
AU2013258107B2 (en) 2017-06-22
RS56255B1 (sr) 2017-11-30
JP6149104B2 (ja) 2017-06-14
PL2847183T3 (pl) 2017-11-30
CL2016001165A1 (es) 2016-12-02
HK1208027A1 (en) 2016-02-19

Similar Documents

Publication Publication Date Title
DOP2014000254A (es) Metodo para la preparacion de compuestos de triazol
CO6900157A2 (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-etoxi-etil}-1h-[1,2,4]triazol sustituidos
CO6900161A2 (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-alcoxi-2-ciclil-etil}-1h-[1,2,4]triazol sustituidos
CO6900158A2 (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-aluiniloxi-etil}-1h-[1,2,4]triazol sustituidos
CO6900159A2 (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-alcoxi-3-metil-butil}-1h-[1,2,4]triazol sustituidos
CO6900160A2 (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-alcoxi-2-alquinil/alquenil-etil}-1h-[1,2,4]triazol sustituidos
SA113340696B1 (ar) تصنيع 2-(5-برومو-4-(4-سيكلو بروبيل نافثالين-1-يل)-4 h-1، 2، 4- ترازول-3- يل ثيو) حمض أسيتيك
MX2018007513A (es) Metodo para producir 2-[4-(4-clorofenoxi)-2-(trifluorometil)fenil] -1-(1,2,4-triazol-1-il)propan-2-ol.
UA111725C2 (uk) Кристалічний (r)-(e)-2-(4-(2-(5-(1-(3,5-дихлорпіридин-4-іл)етоксі)-1h-індазол-3-іл)вініл)-1h-піразол-1-іл)етанол
NZ595553A (en) VINYL INDAZOLYL COMPOUND; (E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol
TN2012000347A1 (en) 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
MA33835B1 (fr) Sels de 4-[2-[[5-méthyl-1-(2-naphtalényl)-1h-pyrazol-3-yl]oxy]éthyl]morpholine
DK2878598T3 (da) Krystallinsk form af 4-[5-(pyridin-4-yl)-1h-1,2,4-triazol-3-yl]pyridin-2-carbonitril
IN2012DN03391A (xx)
AR083887A1 (es) 1-[6-(morfolin-4-il)pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)-1h-pirazol-5-olato sodico
NZ702797A (en) Method for producing 4-[5-(pyridin-4-yl)-1h-1,2,4-triazol-3-yl]pyridine-2-carbonitrile, and intermediate thereof
CL2018003107A1 (es) Procedimiento para la preparación de derivados de 1-fenilo-1,2,4-triazol sustituidos por 5-hidroxialquilo
CL2014001247A1 (es) Forma de dosificacion solida de liberacion inmediata de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]-amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil]-benzamida; metodo de preparacion.
TH152857A (th) วิธีการสำหรับการเตรียมของสารประกอบไตรอาซอล
NZ623098A (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
UA81888U (ru) Соли s-производных 1,2,4-триазолов, которые стимулируют рост льна
TH134802B (th) 5-(เฟนิล/ไพริดินิล-เอไธนิล)-2-ไพริดีน/2-ไพริมิดีน-คาร์บอกซาไมด์ ในรูปตัวคุม mglur5